Synergic activity of D-cycloserine and beta-chloro-D-alanine against Mycobacterium tuberculosis | Zendy

Susana David | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Synergic activity of D-cycloserine and beta-chloro-D-alanine against Mycobacterium tuberculosis

Author(s) -

Susana David

Publication year - 2001

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/47.2.203

Subject(s) - peptidoglycan , cycloserine , microbiology and biotechnology , mycobacterium tuberculosis , in vivo , alanine , mycobacterium , toxicity , tuberculosis , in vitro , bacteria , antibiotics , chemistry , biology , pharmacology , biochemistry , medicine , amino acid , pathology , genetics , organic chemistry

D-Cycloserine (DCS) is a peptidoglycan inhibitor. Although very effective against Mycobacterium tuberculosis, it is seldom employed in the management of this infection due to its high toxicity. beta-Chloro-D-alanine (another peptidoglycan inhibitor) reduces the MIC of DCS from 50 to 2.5 mg/L at a concentration significantly below its MIC for this organism. A reduction in bacterial viability and significant growth inhibition (as quantified by the X/Y quotient for the Bactec radiometric procedure) were observed with subinhibitory concentrations of both drugs. It is suggested that this powerful synergic effect should be the object of in vivo and eventually clinical trials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research